RPB0030

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
SARS-CoV-2 SARS-CoV-2, 2019-nCoV, COVID-19, COVID-19 virus, SARS2, Wuhan coronavirus, Human coronavirus 2019, COVID19, HCoV-19, SARS-2, SARS-CoV4 2697049 Nidovirales Coronaviridae Betacoronavirus Severe acute respiratory syndrome-related coronavirus virus

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
F CTAACAATCTTGATTCTAAGGTTGGTGG 28 0.4 39.3 55.19 8633.67 \
R CTCTCTCAAAAGGTTTGAGATTAGA 25 0.4 36 51.46 7680.08 \

Gene Description

Target Gene GenBank ID
S(containing the L452R mutation site) NC_045512.2

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
provides a strong support to the precise epidemic control and precision medicine of SARS-CoV-2 variants and can be readily developed for the simultaneous genotyping of multiple SARS-CoV-2 mutations. RPA-Pfago \ 30 42 Pfago(fluorescence) single copy per reaction \ \

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2022 Rapid and Sensitive Genotyping of SARS-CoV-2 Key Mutation L452R with an RPA- Pf Ago Method Chenjie Zhao , Lihong Yang , Xue Zhang, Yixin Tang, Yue Wang, Xiaofu Shao, Song Gao, Xin Liu, Pei Wang Analytical Chemistry 36459151 10.1021/acs.analchem.2c03563

Rapid and Sensitive Genotyping of SARS-CoV-2 Key Mutation L452R with an RPA- Pf Ago Method

Author(s):

Chenjie Zhao , Lihong Yang , Xue Zhang, Yixin Tang, Yue Wang, Xiaofu Shao, Song Gao, Xin Liu, Pei Wang

Journal:

Analytical Chemistry

Year:

2022

Abstract:

In the two years of COVID-19 pandemic, the SARS-CoV-2 variants have caused waves of infections one after another, and the pandemic is not ending. The key mutations on the S protein enable the variants with enhanced viral infectivity, immune evasion, and/or antibody neutralization resistance, bringing difficulties to epidemic prevention and control. In support of precise epidemic control and precision medicine of the virus, a fast and simple genotyping method for the key mutations of SARS-CoV-2 variants needs to be developed. By utilizing the specific recognition and cleavage property of the nuclease Argonaute from Pyrococcus furiosus (PfAgo), we developed a recombinase polymerase amplification (RPA) and PfAgo combined method for a rapid and sensitive genotyping of SARS-CoV-2 key mutation L452R. With a delicate design of the strategy, careful screening of the RPA primers and PfAgo gDNA, and optimization of the reaction, the method achieves a high sensitivity of a single copy per reaction, which is validated with the pseudovirus. This is the highest sensitivity that can be achieved theoretically and the highest sensitivity as compared to the available SARS-CoV-2 genotyping assays. Using RPA, the procedure of the method is finished within 1.5 h and only needs a minimum laboratorial support, suggesting that the method can be easily applied locally or on-site. The RPA-PfAgo method established in this study provides a strong support to the precise epidemic control and precision medicine of SARS-CoV-2 variants and can be readily developed for the simultaneous genotyping of multiple SARS-CoV-2 mutations.